“Women and younger people are more likely to be misdiagnosed. Nearly 70% of women were told they had something else, usually a urinary tract infection." (Lydia E Makaroff, PhD, World Bladder Cancer Patient Coalition). Read more https://t.co/dBEO5RyhWM #bladdercancer #EURoundtable

Photocure today reported Hexvix®/Cysview® revenues of NOK 134.1 million in Q2 2025 (Q3 2024: NOK 120.1 million), and an EBITDA of NOK 10.2 million (NOK 5.0 million). Read more:

Photocure is attending the 98th National Congress of the Italian Society of Urology (SIU) in Sorrento, 6–9 November 2025! Visit us at Booth No. 7 at the Hilton Sorrento Palace. We look forward to meeting you there. #SIU2025 #Urology #BladderCancer

Photocure supports the next EAU/ESU UROwebinar “TURBT-related challenges in bladder cancer: Nightmare Cases – Part 2” For Healthcare professionals on 4 Nov 2025, 18:30 CET– register here: https://t.co/IcSuBw7yca #BladderCancer #Urology #NMIBC #UROwebinar #MedicalEducation

Photocure participated in the EU Roundtable on Bladder Cancer in April. Expert recommendations are now published in the Government Gazette. Read more: https://t.co/eg6SDu583B #bladdercancer #EUroundtable #precisiondiagnostics

Photocure participated in the EU Roundtable on Bladder Cancer in April. Expert recommendations are now published in the Government Gazette. Read more: https://t.co/YzkeeuJAth #bladdercancer #EURoundtable

Urinary tract infections share symptoms with #bladdercancer which can cause delays in diagnosing bladder cancer, especially in women. Earlier diagnosis of bladder cancer is important and may improve outcomes for women. This #UrologyWeek, find out more: https://t.co/tpe4BBbkKF

Honored to welcome Prof. Dr. Bernd Wullich, the #DGU2025 Congress President at our booth: Photocure had committed to compensating for the CO2 emissions of its DGU presence & presented him with a young beech tree for the 140+ trees and 85m2 of meadow planted for biodiversity.

Photocure is attending the German Society for Urology (DGU) Congress in Hamburg, 17–20 September 2025! Visit us at Booth H422 in the main exhibition hall and discover our approach to “seeing is believing”. We look forward to meeting you there. #DGU2025 #Urology #bladdercancer

Proud to support the upcoming UROwebinar for healthcare professionals: Follow-up in NMIBC – Room for de-intensification? organized by the European School of Urology and the ESOU on September 23, at 18:30 CEST Join here: https://t.co/CAj7fJ5KyQ #NMIBC #UROwebinar #MedicalEducation

New "Optimizing Bladder Tumor Resection in 2025” webinar in French, for Healthcare professionals, dedicated to TURB practices and innovations: Sept 4, 2025, 6:30 - 7:30 pm CET. https://t.co/Pbg2Ig2BN4 Org: Photocure & KARL STORZ Endoscopy France, technical support by IRCAD.

Photocure today reported Hexvix®/Cysview® revenues of NOK 135.6 million in Q2 2025 (Q2 2024: NOK 122.4 million), and an EBITDA of NOK 14.8 million (27.8 incl. milestones). Read more:

Photocure starts up commercial operations in Spain 🇪🇸 Exciting news: with the launch of our sales, marketing, and direct distribution operations, we aim to bring innovative solutions to the Spanish market & its unique needs. #bladdercancer #expansion https://t.co/aqDBTdQU8F

Photocure is a proud sponsor of BCAN's Walk to End Bladder Cancer. This year, our teams in the U.S. walked in 9 of 19 local walks and raised 100% of our donations goal. Congratulations to BCAN for another successful Walk event! @BladderCancerUS #bladdercancer #BladderCancerAware

A resounding success! “Strong together –​ united against bladder cancer​” is the motto of Photocure’s 3rd Bladder Cancer roadshow that continues through June 26, training healthcare professional teams in #bladdercancer management aspects. #awareness #medicaltraining

Many symptoms of #bladdercancer could at first appear to be something else entirely. Do you have blood in your urine? Be sure it’s not bladder cancer and get checked. #BladderCancerMonth25 #GetChecked @WorldBladderCan

#BladderCancerAwarenessMonth of May: Photocure is once again supporting the Swedish Bladder Cancer Patient organization and their bladder cancer seminar on May 22, 6-8pm CET in Malmö, also being broadcast live: https://t.co/ekVoW7XWNh #bladdercancer #aware #medicaleducation

Bladder Cancer Roadshow again! May is #BladderCancerAwarenessMonth and the tour bus from Photocure and our partners this year, MSD Germany and Olympus Germany, will stop at many hospitals and congresses in Germany and Austria starting tomorrow in Gladbeck!

Photocure today reported Hexvix®/Cysview® revenues of NOK 125.3 million in Q1 2025 (Q1 2024: NOK 116.8 million), and an EBITDA of NOK 1.8 million (7.9). Read more:

Do we need TURBT in MIBC? For healthcare professionals: join Episode 2 of the UROwebinar series on TURBT, focusing on the role of TURBT in MIBC. Register for the webinar 6 May at 18:30 CEST https://t.co/qDlWMUfFR9 #UROwebinar #BladderCancer #TURBT #MIBC #Urology #Medicaleducation